Prescribe Naproxen Over Meloxicam for This 72-Year-Old Patient with Back Pain
For a 72-year-old patient with back pain, naproxen is the preferred choice over meloxicam, but both NSAIDs require careful risk assessment and gastroprotection in this age group. The 2019 American Geriatrics Society Beers Criteria strongly recommends avoiding all NSAIDs (including both meloxicam and naproxen) in older adults due to increased risks of gastrointestinal bleeding, kidney injury, and cardiovascular events 1. However, when NSAIDs are necessary for pain control, naproxen has the most favorable cardiovascular safety profile among available NSAIDs 2.
Key Decision Points
Age-Related Considerations:
- At 72 years old, this patient falls into the high-risk category where NSAID use requires heightened caution 1
- The Beers Criteria note that unbound plasma fraction of naproxen increases in elderly patients, requiring dose adjustment 3
- Use the lowest effective dose for the shortest duration possible 3
Cardiovascular Safety:
- Naproxen is considered among the safest NSAIDs for cardiovascular risk (95.1% of rheumatologists rated it safest) 2
- This is critical in older adults who have higher baseline cardiovascular risk
Gastrointestinal Protection:
- Mandatory co-prescription of a proton pump inhibitor (PPI) is required for any patient ≥65 years receiving NSAIDs 4
- The combination of NSAID + PPI is rated as "appropriate" for patients aged ≥65 years 4
- Without PPI co-prescription, NSAID use alone in this age group is rated as "inappropriate" 4
Specific Prescribing Recommendations
For Naproxen:
- Start with 250-500 mg twice daily (not the higher acute pain doses) 3
- Maximum 1000 mg/day for chronic use in elderly patients 3
- Always prescribe with a PPI 4
- Monitor renal function before and during therapy 1
Why Not Meloxicam:
- While meloxicam showed better GI tolerability than naproxen 750 mg in one trial 5, this advantage diminishes when naproxen is appropriately dosed and combined with PPI
- Meloxicam lacks the established cardiovascular safety profile that naproxen possesses 2
- Recent evidence shows naproxen has stronger efficacy data for back pain specifically 6, 7
Critical Safety Checks Before Prescribing
Absolute Contraindications:
- Active gastroduodenal ulcer (85.4% of clinicians cite this) 2
- Severe renal impairment (creatinine clearance <30 mL/min) 3
- Heart failure with reduced ejection fraction 1
- Concurrent anticoagulation (especially vitamin K antagonists - 96.3% concern rate) 2
Required Monitoring:
- Baseline renal function (creatinine, BUN) - though only 13.4% routinely do this, it should be standard 2
- Blood pressure monitoring
- Signs of GI bleeding
Evidence Quality Note
The recommendation for naproxen over meloxicam is based on convergent evidence: the Beers Criteria 1 provides strong guidance on NSAID use in elderly (though recommending avoidance when possible), the 2004 gastroprotection guidelines 4 provide clear algorithms for appropriate NSAID + PPI use in older adults, and recent systematic reviews 6, 7 support naproxen's efficacy for back pain specifically.
The bottom line: If you must use an NSAID in this 72-year-old, prescribe naproxen 250-500 mg twice daily with a PPI, use the shortest duration possible (ideally <2 weeks), and ensure renal function is adequate before starting.